IIS Receives CE Mark Approval For Marketing First Implantology Related Dental Product, ImplantLock Device

Innovative Implant Solutions Ltd. (IIS), an Israeli start-up and leading developer of implantology related dental products, today, announces that they received the European CE Mark approval to market its first product, the ImplantLock device, providing standard, root-form implants with the ability to secure real-time "Functional Immediate Loading" or "Immediate Functional Occlusion" regardless of bone density and height.



The patent- pending ImplantLock device is an add-on anchor that provides standard, root- form implants with the ability to secure real-time "Functional Immediate Loading" or "Immediate Functional Occlusion", regardless of bone density and height. The device can be used to support standard implants of any length including very short implants (down to 6.0 mm in length) and thus reduce the need for many bone augmentation and sinus lift procedures. In addition, the device enables safe and stable "Immediate implants' placement after tooth extraction.


Currently standard implants have only one point of contact with the hard, cortical bone. This limitation prevents them from bearing loaded for a period of 3-6 moths; until integration with the soft bone (osseointegration) is achieved. Moreover, when a bone augmentation or a sinus lift procedure is performed, reaching the stage of complete functional loading may take up to 9 months. Yet by providing each implant with 9 points of anchorage in the hard, cortical bone, the ImplantLock device eliminates the need for any postponement of loading.


"Receiving the CE mark approval for our ImplantLock device is a significant step for IIS and indicates that the product complies with the appropriate quality and safety standards. We have taken a huge step forward," states Jacob Kaufman, CEO of IIS.


Oren Gershtein, CEO of Van Leer Ventures Jerusalem, said, "Thanks to IIS's unique technology they were able to reach this significant milestone in such a short time. The company's sales and profit prospects for their line of products are highly encouraging based on the European CE Mark approval. The potential for the success of this product in the dental implant device market is very high and estimated at over $300 million a year. We are certain that both the patient and the physician will find an increase in level of satisfaction with the improvement that this device brings."


About IIS


Innovative Implant Solutions (IIS) is an Israeli start up company focusing on developing a line of implantology related dental product operating within the framework of Van Leer Ventures in Jerusalem as part of the Chief Scientist incubator program. IIS has recently obtained a special grant of a third year incubator support by the Chief Scientist of the Ministry of Trade and Industry in Israel.


IIS was founded in 2006, by Dr. Serge Goldman, a dental Surgeon with 20 years experience in Dentistry and Oral Surgery, with degrees and certificates in Dental Surgery, Oral Biology, Periodontology and Implantology, and Jacob Kaufman, a specialist in Business Development with over 20 years experience in managing commercial activities of startup companies with innovative technologies. In addition the company's consultants include a prominent Oral & Maxillofacial surgeon and two leading Periodontists, all of whom are heading departments in the Hadassah Medical Center in Jerusalem, as well as a highly experienced practical Physicist, formerly the Chief R&D Engineer at Applied Materials. implantlock


About Van Leer Ventures


Van Leer Ventures Jerusalem (VLVJ) invests in early stage companies with proprietary innovative technologies addressing large and fast growing markets. VLVJ focuses on a number of fields: IT, Advanced Materials, Nanotechnology, Medical Devices and Industrial Applications. The company is committed to providing its portfolio companies with advanced technological facilities, management services & funding through all stages of the life cycle of their project to exploitation of technological and financial results, raising funds from VC's and leading Investment Homes. The Center was established in 1992 by a consortium of notable sponsors. Today much of the Center's activities are supported by its investors, Docor International BV, an industrial investment fund backing graduate companies in Israel and around the world, and proves a suitable partner for advancing technologies from innovation to commercialization. Van Leer's wide network of contacts contributes greatly in helping their portfolio companies recruit international partnerships.

Innovative Implant Solutions